The defining molecular alterations of this tumour are missense mutations of IDH1 or IDH2, in addition to the deletion of the whole arm of chromosomes 1p and 19q, with mutations in IDH1/2 thought to be an early alteration that drives tumourigenesis prior to the establishment of 1p19q co-deletion [24]. The gene discussed is IDH2; the disease is neoplasm.